Surmeli, Zeki <br/><br/>
Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway.  [electronic resource] 

 -  Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine  Mar 2016 
 - 3665-73 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1423-0380 
<br/><br/><label>Standard No.: </label>10.1007/s13277-015-3265-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Breast Neoplasms--metabolism<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Diphosphonates--pharmacology<br/>Dose-Response Relationship, Drug<br/>Drug Synergism<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Humans<br/>Imidazoles--pharmacology<br/>MCF-7 Cells<br/>Marine Toxins<br/>Okadaic Acid--pharmacology<br/>Oxazoles--pharmacology<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphoprotein Phosphatases--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Signal Transduction--drug effects<br/>Zoledronic Acid